These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 19808540)

  • 1. "Feeling the RAGE" in the atherosclerotic vessel wall.
    Fayad ZA; Vucic E
    Circ Cardiovasc Imaging; 2008 Nov; 1(3):178-9. PubMed ID: 19808540
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel monoclonal antibody for RAGE-directed imaging identifies accelerated atherosclerosis in diabetes.
    Tekabe Y; Luma J; Einstein AJ; Sedlar M; Li Q; Schmidt AM; Johnson LL
    J Nucl Med; 2010 Jan; 51(1):92-7. PubMed ID: 20008983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why is CTX all the RAGE?
    Du Pasquier L; Chrétien I
    Res Immunol; 1996 May; 147(4):261-6. PubMed ID: 8844904
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of receptor for advanced glycation end products-directed imaging of atherosclerotic plaque in a murine model of spontaneous atherosclerosis.
    Tekabe Y; Li Q; Rosario R; Sedlar M; Majewski S; Hudson BI; Einstein AJ; Schmidt AM; Johnson LL
    Circ Cardiovasc Imaging; 2008 Nov; 1(3):212-9. PubMed ID: 19808545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Receptors for advanced glycation end products and their physiological and clinical significance].
    Pietkiewicz J; Seweryn E; Bartyś A; Gamian A
    Postepy Hig Med Dosw (Online); 2008 Oct; 62():511-23. PubMed ID: 18936727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the influence of renal function on the prognostic value of advanced glycation end-products and sRAGE in heart failure?
    Hartog JW; Willemsen S; Voors AA
    J Card Fail; 2008 Sep; 14(7):626; author reply 627-8. PubMed ID: 18722329
    [No Abstract]   [Full Text] [Related]  

  • 7. Accumulation of advanced glycation end products in women with preeclampsia: possible involvement of placental oxidative and nitrative stress.
    Chekir C; Nakatsuka M; Noguchi S; Konishi H; Kamada Y; Sasaki A; Hao L; Hiramatsu Y
    Placenta; 2006; 27(2-3):225-33. PubMed ID: 16338468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced glycosylation end products might promote atherosclerosis through inducing the immune maturation of dendritic cells.
    Ge J; Jia Q; Liang C; Luo Y; Huang D; Sun A; Wang K; Zou Y; Chen H
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2157-63. PubMed ID: 16100036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature.
    Yan SF; Ramasamy R; Schmidt AM
    Circ Res; 2010 Mar; 106(5):842-53. PubMed ID: 20299674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycated and carboxy-methylated proteins do not directly activate human vascular smooth muscle cells.
    Ballinger ML; Thomas MC; Nigro J; Ivey ME; Dilley RJ; Little PJ
    Kidney Int; 2005 Dec; 68(6):2756-65. PubMed ID: 16316350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble forms of RAGE: an index of vascular stress? A commentary on "Soluble RAGE in type 2 diabetes: association with oxidative stress".
    Nawroth PP; Stern DM
    Free Radic Biol Med; 2007 Aug; 43(4):506-10. PubMed ID: 17640560
    [No Abstract]   [Full Text] [Related]  

  • 12. Advanced glycation end products and its receptor (RAGE) are increased in patients with COPD.
    Wu L; Ma L; Nicholson LF; Black PN
    Respir Med; 2011 Mar; 105(3):329-36. PubMed ID: 21112201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of bone marrow-derived receptor for advanced glycation end products inhibits atherosclerotic plaque progression.
    Morris-Rosenfeld S; Blessing E; Preusch MR; Albrecht C; Bierhaus A; Andrassy M; Nawroth PP; Rosenfeld ME; Katus HA; Bea F
    Eur J Clin Invest; 2011 Nov; 41(11):1164-71. PubMed ID: 21418204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAGE (receptor for advanced glycation end products): a central player in the inflammatory response.
    Chavakis T; Bierhaus A; Nawroth PP
    Microbes Infect; 2004 Nov; 6(13):1219-25. PubMed ID: 15488742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-Reactive protein upregulates receptor for advanced glycation end products expression in human endothelial cells.
    Zhong Y; Li SH; Liu SM; Szmitko PE; He XQ; Fedak PW; Verma S
    Hypertension; 2006 Sep; 48(3):504-11. PubMed ID: 16847147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury.
    Soulis T; Thallas V; Youssef S; Gilbert RE; McWilliam BG; Murray-McIntosh RP; Cooper ME
    Diabetologia; 1997 Jun; 40(6):619-28. PubMed ID: 9222639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could receptors for advanced glycation end products be considered cardiovascular risk markers in obese children?
    de Giorgis T; D'Adamo E; Giannini C; Chiavaroli V; Scarinci A; Verrotti A; Chiarelli F; Mohn A
    Antioxid Redox Signal; 2012 Jul; 17(2):187-91. PubMed ID: 22315985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of advanced glycation end products (AGE) and soluble receptor for AGE (sRAGE) in vascular complications in diabetes].
    Yamagishi S
    Nihon Rinsho; 2012 Jul; 70 Suppl 5():243-7. PubMed ID: 23156401
    [No Abstract]   [Full Text] [Related]  

  • 19. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses.
    Schmidt AM; Yan SD; Yan SF; Stern DM
    J Clin Invest; 2001 Oct; 108(7):949-55. PubMed ID: 11581294
    [No Abstract]   [Full Text] [Related]  

  • 20. Age associated changes of AGE-receptor expression: RAGE upregulation is associated with human heart dysfunction.
    Simm A; Casselmann C; Schubert A; Hofmann S; Reimann A; Silber RE
    Exp Gerontol; 2004 Mar; 39(3):407-13. PubMed ID: 15036400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.